Ethics of clinical research with mentally ill persons

European Archives of Psychiatry and Clinical Neuroscience

Volumn 262, Issue 5, 2012, Pages 441-452

  Helmchen, Hanfried ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Ethics of psychiatric research; Incapacity to consent; Mentally ill subjects; Risk benefit relationship; Standards of benefits and risks

Indexed keywords

ARTICLE; CLINICAL RESEARCH; HUMAN; INFORMED CONSENT; MEDICAL ETHICS; MENTAL DISEASE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS;

BIOMEDICAL RESEARCH; CLINICAL TRIALS AS TOPIC; HUMANS; INFORMED CONSENT; MENTAL COMPETENCY; MENTAL DISORDERS; MENTALLY ILL PERSONS;

EID: 84864971173     PISSN: 09401334     EISSN: 14338491     Source Type: Journal    
DOI: 10.1007/s00406-011-0287-2     Document Type: Article

References (97)

1. Propping P (2010) Genetics: ethical implications of research, diagnostics and counseling. In: Helmchen H, Sartorius N (eds) Ethics in psychiatry. Springer, Dordrecht
2. Meltzer H, Brugha TS (2010) Ethical concerns in carrying out surveys of psychiatric morbidity. In: Helmchen H, Sartorius N (eds) Ethics in psychiatry. Springer, Dordrecht
3. Nuffield Council on Bioethics (2007) Public health: ethical issues. Nuffield Council on Bioethics, London
4. Petrini C (2010) Ethical issues in translational research. Perspect Biol Med 53:517-533
5. AK Versorgungsforschung im Wissenschaftlichen Beirat der Bundesärztekammer. Definition und Abgrenzung der Versorgungsforschung. http://www.bundesaerztekammer.de/downloads/Definition. pdf. 2004
6. World Medical Association (WMA) (2008) Declaration of Helsinki 2008.http://www.wma.net/e/policy/b3.htm
7. Appelbaum PS (2011) Can a theory of voluntariness be a priori and value-free? Am J Bioeth 12:17-35
8. Kamp G (2009) Arguments from instrumentalization. Newsletter d.Europäischen Akademie, Bad Neuenahr1-3
9. Sass HM (1983) Reichsrundschreiben 1931: pre-nuremberg german regulations concerning new therapy and human experimentation. J Med Philos 8:99-111
10. Nuremberg Code (2011) http://ohsr.od.nih.gov/guidelines/nurem berg.html
11. Gefenas E (2007) Balancing ethical principles in emergency medicine research. Sci Eng Ethics 13:281-288
12. Tarini BA, Burke W, Scott CR, Wilfond BS (2008) Waiving informed consent in newborn screening research: balancing social value and respect. Am J Med Genet C Semin Med Genet 148C:23-30 (Pubitemid 351294849)
13. Steiner T, Walter-Sack I, Taupitz J, Hacke W, Strowitzki T (2008) Ethische und juristische Aspekte beim Einschluss nicht einwilligungsfähiger Patienten in Akuttherapie-Studien: Beispiel einer Arzneimittelstudie zur Behandlung intrazerebraler Blutungen: das Heidelberger Verfahren. Legal and ethic rationales of including patients unable to consent into clinical trials. DMW 133:787-792 (Pubitemid 351828380)
14. Kroll T, Morris J (2009) Challenges and opportunities in using mixed method designs in rehabilitation research. Arch Phys Med Rehabil 90:S11-S16
15. Alexander SJ (2010) As long as it helps somebody': why vulnerable people participate in research. Int J Palliat Nurs 16:174-179
16. Macklin R (2010) Enrolling pregnant women in biomedical research. Lancet 375:632-633
17. Oquendo MA, Stanley B, Ellis SP, Mann JJ (2004) Protection of human subjects in intervention research for suicidal behaviour. Am J Psychiatry 161:1558-1563 (Pubitemid 39201450)
18. Knoepffler N (2008) Research: ethical norms for medical research on humans]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 51:880-886
19. Mihai A, Damsa C, Allen M, Baleydier B, Lazignac C, Heinz A (2007) Viewing videotape of themselves while experiencing delirium tremens could reduce the relapse rate in alcoholdependent patients. Addiction 102:226-231 (Pubitemid 46096283)
20. Habermann E, Lasch H, Gódicke P (2000) Therapeutische Prü- fung an nichteinwilligungsfähigen im Eilfall: ethisch geboten und rechtlich zulässig? NJW 46:3389-3395
21. Rittner C (2007) Ein Modell Für die Forschung an einwilligungsunfähigen (bewußtlosen) Patienten. MedR 25:340-344
22. aΓaçØ : acute informed consent to participation in a trial of thrombolysis for stroke. J Med Ethics 34:751-756
23. Kölch M, Ludolph AG, Plöner PL, Fangerau H, Vitiello B, Fegert JM (2010) Safeguarding children's rights in psychopharmacological research: ethical and legal issues. Curr Pharm Des 16:2398-2406
24. Eriksson S (2010) On the need for improved protections of incapacitated and non-benefitting research subjects. Bioethics [epub ahead (PMID: 20184559)]
25. Parvizi J, Chakravarty R, Og B, Rodriguez-Paez A (2008) Informed consent: is it always necessary? Injury 39:651-655
26. Glass KC, Binik A (2008) Rethinking risk in pediatric research. J Law Med Ethics 36:567-576
27. Helmchen H (2008) Clinical research in the mentally ill. Ethical considerations. In: Thiele F, Fegert JM, Stock G (eds) Clinial research in minors and the mentally ill. Europäische Akademie zur Erforschung von der Folgen wissenschaftlich-technischer Entwicklungen, Bad Neuenahr-Ahrweiler
28. Appelbaum PS (2007) Assessment of patient's competence to consent to treatment. NEJM 357:1834-1840
29. Kim SY, Appelbaum PS, Kim HM, Wall IF, Bourgeois JA, Frankel B, Hails KC, Rundell JR, Seibel KM, Karlawish JH (2011) Variability of judgments of capacity: experience of capacity evaluators in a study of research consent capacity. Psychosomatics. 52:346-353
30. Dunn LB, Nowrangi MA, Palmer BW, Jeste DV, Saks ER (2006) Assessing decisional capacity for clinical research or treatment: a review of instruments. Am J Psychiatry 163:1323-1334 (Pubitemid 44464400)
31. Okai D, Owen G, McGuire H, Singh S, Churchill R, Hotopf M (2007) Mental capacity in psychiatric patients: Systematic review. Br J Psychiatry 191:291-297 (Pubitemid 47555977)
32. Roberts LW, Warner TD, Nguyen KP, Geppert CM, Rogers MK, Roberts BB (2003) Schizophrenia patients' and psychiatrists' perspectives on ethical aspects of symptom re-emergence during psychopharmacological research participation. Psychopharmacology (Berl) 171(1):58-67 (Pubitemid 38134671)
33. Simonsen S (2009) Acceptable risk and the requirement of proportionality in European Biomedical Research Law. What does the requirement that biomedical research shall not involve risks and burdens disproportionate to its potential benefits mean? Norwegian University of Science and Technology (NTNU), Trondheim
34. Weisstub DN (2002) Honor, dignity, and the framing of multiculturalist values. In: Kretzmer D, Klein E (eds) The concept of human dignity in human rights discourse. KluwerInternational Law, The Hague
35. Macklin R (2003) Dignity is a useless concept. It means no more than respect for persons or their autonomy. BMJ 327:1419-1420
36. Rajczi A (2004) Making risk-benefit assessments of medical research protocols. J Law Med Ethics 32:338-348 (Pubitemid 38903360)
37. National Bioethics Advisory Commission (NBAC) (2005) Part 46 Protection of human subjects. http://ohsr.od.nih.gov/guidelines/ 45cfr46.html#46.406, 26 September 2011
38. Wendler D, Miller FG (2007) Assessing research risks systematically: the net risks test. J Med Ethics 33:481-486
39. Wiesing U (2011) Comments on "Ethics of clinical resarch with mentally ill persons"
40. Hüppe A, Raspe H (2011) Mehr Nutzen als Schaden? Nutzenund Schadenpotenziale von Forschungsprojekten einer Medizinischen Fakultät: eine empirische Analyse. Ethik Med 23:107-121
41. Deutscher Bundestag. Sozialgesetzbuch (SGB), Fünftes Buch (V), Gesetzliche Krankenversicherung. Zuletzt geändert durch Art. 2 G v. 22.12.2010 I 2309. http://www.sozialgesetzbuch.de/gesetze/05/index.php. 22-12-2010. 4-4-2011
42. European Guideline for Good Clinical Practice (ICH-GCPGuideline E6) in 1996/Directive 2001/20/EC. http://www.eortc. be/Services/Doc/clinical-EU- directive-04-April-01.pdf. 2011. 26-9-2011
43. Deutscher Bundestag. Arzneimittelgesetz (AMG), incl. 12. Novelle 2004. http://www.gesetze-im-internet.de/amg-1976/BJNR024480976.html. 1975
44. Food and Drug Administration (FDA). http://www.fda.gov/. 2011. 26-9-2011
45. European Medicines Agency (EMA) (2011) http://www.ema.europa.eu/ema/ index.jsp?curl=/pages/home/Home-Page.jsp&jsenabled=true
46. Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM) (2011) http://www.bfarm.de/DE/Home/home-node.html. 26-9-2011
47. Swissmedic-Schweizerisches Heilmittelinstitut (2011) http:// www.swissmedic.ch/. 26-9-2011
48. National Institute for Health and Clinical Excellence (NICE) in the United Kingdom (2011) http://www.nice.org.uk/
49. Institut Für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) (2011)www.iqwig.de/
50. Möller HJ, Maier W (2010) Evidence-based medicine in psychopharmacotherapy: possibilities, problems and limitations. Eur Arch Psychiatry Clin Neurosci 260:25-39
51. Wendler D, Krohmal B, Eanuel EJ, Grady C, ESPRIT Group (2008) Why patients continue to participate in clinical research. Arch Intern Med 168:1294-1299 (Pubitemid 351930836)
52. Sofaer N, Jafarey A, Lei RP, Zhang X, Wikler D (2007) Unconditional compensation: reducing the costs of disagreement about compensation for research subjects. East Mediterr Health J 13:6-16 (Pubitemid 47243835)
53. Connell CM, Shaw B, Holmes SB, Forster NL (2001) Caregivers' attitudes toward their family members' participation in Alzheimer disease research: implications for recruitment and retention. Alzheimer Dis Assoc Disord 15:137-145 (Pubitemid 32807938)
54. Mastwyk M, Ritchie CW, LoGiudice D, Sullivan KA, Macfarlane S (2002) Carers' impressions of participation in Alzheimer's disease clinical trials: What are their hopes? And is it worth it? 14:37-45
55. International Psychogeriatrics 14:39-45
56. Friedman A, Robbins E, Wendler D (2010) Which benefits of research participation count as 'direct'? Bioethics. PMID: 20497168 [PubMed-as supplied by publisher] PMCID: PMC2945615 [Available on 2011/11/17]
57. Vollmann J (2000) "Therapeutische" versus "nicht- therapeutische" Forschung: eine medizinethische plausible Differenzierung? Ethik Med 12:65-74
58. Helmchen H (2002) Biomedizinische Forschung mit einwilligungsunfä higen Erwachsenen. In: Taupitz J (ed) Das Menschenrechtsúbereinkommen zur Biomedizin des Europarates: taugliches Vorbild fü r eine weltweit geltende Regelung? Springer, Berlin
59. Council of Europe (2011) Convention for the protection of human rights and dignity of the human being with regard to the application of biology and medicine: convention on human rights and biomedicine. http://conventions.coe. int/Treaty/en/Treaties/html/ 164.htm. 26-9-2011
60. Council of Europe. Draft Additional Protocol to the Convention on Human Rights and Biomedicine, on Biomedical Research. http://www.iqb.es/leyes/ protocolo%20al%20convenio%20de%20 derechos%20humanos%20y%20biomedicina.pdf. 23-8-2003
61. Council of Europe (2011) Explanatory report: convention for the protection of human rights and dignity of the human being with regard to the application of biology and medicine: convention on human rights and biomedicine. http://conventions.coe.int/treaty/en/Reports/Html/164.htm
62. Walter H, Berger M, Schnell K (2009) Neuropsychotherapy: conceptual, empirical and neuroethical issues. Eur Arch Psychiatry Clin Neurosci 259:173-182
63. Castonguay LG (2011) Controlling is not enough: the importance of measuring the process and specific effectiveness of psychotherapy treatment and control conditions. Ethics Behav 12:31-42
64. Taupitz J (Hrg) (2002) Das Menschenrechtsúbereinkommen zur Biomedizin des Europarates. Springer, Berlin, Heidelberg, New York
65. Wendler D (2008) Is it possible to protect pediatric research subjects without blocking appropriate research? J Pediatr 152(4):467-470 (Pubitemid 351384783)
66. Wendler D, Belsky L, Thompson KM, Emanuel EJ (2005) Quantifying the federal minimal risk standard: implications for pediatric research without a prospect of direct benefit. JAMA 294:826-832 (Pubitemid 41178967)
67. Wendler D (2009) Minimal risk in pediatric research as a function of age. Arch Pediatr Adolesc Med 163:115-118
68. Resnik DB (2005) Eliminating the daily risks standard from the definition of minimal risk. J Med Ethics 31:35-38 (Pubitemid 40214693)
69. Zentrale Ethikkommission bei der Bundesärztekammer (1997) Stellungnahme "Zum Schutz nicht-einwilligungsfähiger Personen in der medizinischen Forschung". Deutsches Á rzteblatt 94:B811-B812
70. Kopelman LM, Murphy TF (2004) Ethical concerns about federal approval of risky pediatric studies. Pediatrics 113(6):1783-1789 (Pubitemid 38697992)
71. Wendler D, Emanuel EJ (2005) What is a "minor" increase over minimal risk? J Pediatr 147(5):575-578
72. Westra AE, Engberts DP, Sukhai RN, Wit JM, de Beaufort ID (2010) Drug development for children: how adequate is the current European ethical guidance? Arch Dis Child 95:3-6
73. Office for Human Research Protections (OHRP). Federal Policy for the Protection of Human Subjects (Often referred to as the "Common Rule"). http://www.hhs.gov/ohrp/humansubjects/ commonrule/index.html. 26-9-2011
74. Iltis A (2007) Pediatric research posing a minor increase over minimal risk and no prospect of direct benefit: challenging 45 CFR 46.406. Account Res 14:19-34
75. Fisher CB, Kornetsky SZ, Prentice ED (2007) Determining risk in pediatric research with no prospect of direct benefit: time for a national consensus on the interpretation of federal regulations. Am J Bioeth 7:5-10 (Pubitemid 46417411)
76. Helmchen H, Lauter H (1995) Dürfen Ärzte mit Demenzkranken forschen? Analyse des Problemfeldes Forschungsbedarf und Einwilligungsproblematik. Thieme, Stuttgart, New York
77. Terwey JH (2007) Die Struktur ethisch relevanter Kategorien medizinischer Forschung am Menschen. Medizinische Fakultät der Universität Göttingen
78. Hoffmann M, Schöne-Seifert B (2007) Equipoise: ein Kriterium für die ethische zulässigkeit klinischer Studien? In: Boos J, Merkel R, Raspe H, Schöne-Seifert B (eds) Nutzen und Schaden aus klinischer Forschung am Menschen. Abwägung, Equipoise und normative Grundlagen., Köln. Deutscher Ärzteverlag, Köln
79. Freedman B (1987) Equipoise and the ethics of clinical research. N Engl J Med 317:141-145 (Pubitemid 17092151)
80. London AJ (2007) Clinical equipoise: foundational requirement or fundamental error? In: Steinbock B (ed) The Oxford handbook of bioethics. Oxford University Press, Oxford
81. Djulbegovic B, Lacevic M, Cantor A, Fields KK, Bennett CL, Adams JR, Kuderer NM, Lyman GH (2000) The uncertainty principle and industry-sponsored research 2883. Lancet 356:635-638 (Pubitemid 30627590)
82. Miller PB, Weijer C (2007) Equipoise and the duty of care in clinical research: a philosophical response to our critics. J Med Philos 32:117-133 (Pubitemid 46598158)
83. Magnus D, Merkel R (2007) Normativ-rechtliche Grundlagen der Forschung an nichteinwilligungsfähigen. In: Boos J, Merkel R, Raspe H, Schöne-Seifert B (eds) Nutzen und Schaden aus klinischer Forschung am Menschen. Abwägung, Equipoise und normative Grundlagen. Deutscher Ärzteverlag, Köln
84. Appelbaum PS, Lidz CW (2008) Re-evaluating the therapeutic misconception: response to Miller and Joffe. Kennedy Inst Ethics J 16:367-373
85. Möller HJ, Broich K (2010) Principle standards and problems regarding proof of efficacy in clinical psychopharmacology. Eur Arch Psychiatry Clin Neurosci 260:3-16
86. Tinetti ME, Bogardus ST Jr, Agostini JV (2004) Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med 351:2870-2874
87. Miller FG, Brody H (2005) Viewpoint: professional integrity in industry-sponsored clinical trials. Acad Med 80:899-904 (Pubitemid 41376921)
88. Weijer C, Miller PB (2007) Refuting the net risks test: a response to Wendler and Miller's "Assessing research risks systematically. J Med Ethics 33:487-490
89. Gifford F (2010) Pulling the plug on clinical equipoise: a critique of Miller and Weijer. Kennedy Inst Ethics J 17:203-226
90. Miller FG, Brody H (2007) Clinical equipoise and the incoherence of research ethics. J Med Philos 32:151-165 (Pubitemid 46598162)
91. Resnik DB (2010) Public trust as a policy goal for research with human subjects. Am J Bioethics 10:15-17
92. Helmchen H (2004) Ethical implications of relationships between psychiatrists and pharmaceutical industry. http://www.wfsbp.org/publications. html
93. DeAngelis CD, Fontanarosa PB (2010) Strengthening the credibility of clinical research. Lancet 376:234
94. Fava GA (2010) Conflicts of Interest. In: Helmchen H, Sartorius N (eds) Ethics in psychiatry. Springer, Dordrecht
95. Choudhry NK, Stelfox HT, Detsky AS (2002) Relationships between authors of clinical practice guidelines and the pharmaceutical industry. JAMA 287(5):612-617 (Pubitemid 34252013)
96. Maclean A (2009) Autonomy, informed consent and medical law. Cambridge University Press, New York
97. Editorial The Lancet (2009) Teaching responsible conduct of research. Lancet 374:1568.